Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
GERNGeron(GERN) Zacks Investment Research·2024-05-02 21:21

Geron (GERN) came out with a quarterly loss of 0.09pershareversustheZacksConsensusEstimateofalossof0.09 per share versus the Zacks Consensus Estimate of a loss of 0.10. This compares to loss of 0.07pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof100.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 10%. A quarter ago, it was expected that this drugmaker would post a loss of 0.10 per share when it actually produced a loss of $0.09, delivering a surprise of 10%. Over the last four quarters, the company has surpassed consensus ...